

Fundamental dimension Equity attribute | ENTGPeer $134.35▲+4.71% Cap $20.53BP/E 67.2x QuantScore45/100 | ACLSPeer $106.58▲+1.76% Cap $3.29BP/E 35.5x QuantScore47/100 | ASMXFLeader $793.97▼-6.79% Cap $38.89BP/E 31.9x QuantScore52/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
35/100 |
26/100 |
25/100 |
Valuation Multiples, PEG & DCF upside | 18/100 | 30/100 | 47/100 |
Health Piotroski, Altman Z, leverage & liquidity | 64/100 | 84/100 | 87/100 |
Growth Revenue / earnings growth & margins | 20/100 | 13/100 | 50/100 |
Sentiment Analyst ratings, targets & revisions | 88/100 | 80/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 67.2x | 35.5x | 31.9x |
Forward P/E (next FY) | 34.1x | 26.0x | 33.5x |
EV / EBITDA (TTM) | 27.0x | 24.9x | 22.4x |
Price / Sales | 6.2x | 3.8x | 10.2x |
Price / Free Cash Flow | 35.7x | 50.2x | 49.9x |
PEG ratio | 32.92 | -0.92 | 0.30 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 4 / 9 | 6 / 9 |
Altman Z-Score | 4.23 (Safe) | 8.25 (Safe) | 15.03 (Safe) |
Total debt / equity | 0.86 | 0.04 | 0.02 |
Quick ratio | 1.8x | 3.2x | 1.7x |
Interest coverage | 5.2x | 17.2x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -1.4% | -17.6% | +8.2% |
Net income growth YoY | -19.5% | -40.2% | +5.5% |
Gross margin (TTM) | 45.5% | 43.0% | 51.8% |
Operating margin (FY) | 28.9% | 14.2% | 29.9% |
FCF margin (FY) | 12.4% | 12.8% | 26.8% |
5. Trailing price performancePrice change over period |
1M return | -9.5% | -8.2% | -19.2% |
3M return | +4.2% | -20.5% | -17.8% |
6M return | -13.8% | -25.5% | -20.6% |
Year to date | +59.7% | +32.7% | +29.7% |
1Y return | +47.0% | +27.9% | +22.0% |
3Y return | +47.5% | -28.8% | +97.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $37.72 -71.9% premium | $59.18 -44.5% premium | $177.20 -77.7% premium |
Wall Street consensus target | $186.56 +38.9% · range $115.00–$215.00 | $140.00 +31.4% · range $140.00–$140.00 | — — |
Consensus stance | 70% Buy26% Hold4% Sell | 77% Buy15% Hold8% Sell | — |